6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bar, V; Börzsönyi, M; Csik, M; Pinter, A; Surján, A; Torok, G | 1 |
| Eady, JJ; Haslinger, RK; Peacock, JH; Schlappack, OK; Schmidt, WF | 1 |
2 other study(ies) available for 6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) and Lung Neoplasms
| Article | Year |
|---|---|
Inhibition by an antioxidant of the carcinogenic effect of nitrosomorpholine formed in vivo.
Topics: Animals; Antioxidants; Carcinogens; Female; Lung Neoplasms; Mice; Mice, Inbred Strains; Morpholines; Neoplasms, Experimental; Nitrites; Nitrosamines; Quinolines | 1982 |
Lack of radiosensitization in Lewis lung carcinoma and a murine plasmacytoma by MTDQ and MTDQ-DA.
Topics: Animals; Female; Lung Neoplasms; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Misonidazole; Plasmacytoma; Quinolines; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1988 |